Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
56.94
+0.47 (+0.83%)
Official Closing Price
Updated: 4:10 PM EDT, Sep 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CVS Health Corp
< Previous
1
2
3
4
5
6
7
8
9
...
40
41
Next >
Unpacking the Latest Options Trading Trends in CVS Health
February 29, 2024
Via
Benzinga
3 Top REITs to Strengthen Your Portfolio in Q1
February 27, 2024
One of the best ways to strengthen your portfolio and generate consistent income is with dependable, top REITs that offer dividends.
Via
InvestorPlace
Hackers Behind MGM Resorts, Caesars Entertainment Security Breach, Targeted UnitedHealth's Prescription Deliveries
February 27, 2024
Ongoing tech outage at UnitedHealth linked to 'Blackcat' ransomware. Alphabet's cybersecurity unit, Mandiant investigates.
Via
Benzinga
Topics
Hacking
Exposures
Information Security
Demystifying CVS Health: Insights From 5 Analyst Reviews
February 26, 2024
Via
Benzinga
Is The Economy About To Fall Off The Financial Cliff?
February 25, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Check Out What Whales Are Doing With CVS
February 13, 2024
Via
Benzinga
Critical Insights From CVS Health Analyst Ratings: What You Need To Know
February 08, 2024
Via
Benzinga
CVS Beats Q4 Forecasts with $93.8B Revenue and $2.12 EPS
February 07, 2024
CVS Health Corp. reported a successful Q4 2023, achieving $93.8 billion in revenue.
Via
Talk Markets
It’s Time! 3 Overplayed REITs to Sell in February
February 25, 2024
Various REITs are overvalued. Don't hang on to them for too long as serious drawdowns could occur in the following months.
Via
InvestorPlace
3 Cash Cows to Boost Your Confidence During the February Chill
February 18, 2024
The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns.
Via
InvestorPlace
2008 'Big Short' Oracle Burry Bets Big On Chinese Giants, Backs Google, Amazon's AI Wave
February 14, 2024
Michael Burry, the visionary investor, made significant changes to his portfolio in Q4 2023. Increased stakes in Chinese retailers and two US tech giants, divested from four companies and reduced...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
U.S. Weekly Fundflows Insight Report: Equity ETFs, Conventional Funds Suffer Net Redemptions For The Fund-Flows Week
February 08, 2024
Investors were net sellers of fund assets (including those of conventional funds and ETFs) for the second week in three, redeeming a net $15.7 billion for the LSEG Lipper fund-flows week ended...
Via
Talk Markets
Topics
ETFs
Earnings Scheduled For February 7, 2024
February 07, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via
Benzinga
Earnings Preview: CVS Health
February 06, 2024
Via
Benzinga
What the Options Market Tells Us About CVS Health
February 05, 2024
Via
Benzinga
What's Going On With Health Insurance Firm UnitedHealth Stock Today?
February 08, 2024
Explore UnitedHealth Group Inc stock insights! Discover recent market trends, CEO perspectives, and financial highlights.
Via
Benzinga
The 3 Most Undervalued Stocks With Strong Fundamentals to Buy in February 2024
February 07, 2024
If you are on the hunt for undervalued stocks, look no further than these three companies with strong fundamentals.
Via
InvestorPlace
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
February 07, 2024
Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CVS Health Unusual Options Activity For February 02
February 02, 2024
Via
Benzinga
CVS Health (CVS) Q4 2023 Earnings Call Transcript
February 07, 2024
CVS earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
CVS Health's Q4 Earnings Relieve Investor Concerns But Lowers 2024 Profit Guidance Citing Elevated Medical Cost Trends
February 07, 2024
CVS Health beats Q4 expectations with $2.12 adjusted EPS, allays concerns over healthcare costs. Sales rise 11.9% to $93.81 billion.
Via
Benzinga
Nasdaq, S&P 500 Futures Stall As Rate Worries Dampen Earnings Cheer: Why This Analyst Isn't Worried 'Too Much' About Short-Term Risks
February 07, 2024
The focus once again shifts to speeches by Federal Reserve officials, as traders seek clarity on the potential schedule for rate cuts.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
The 3 Most Undervalued S&P 500 Stocks to Buy in February 2024
February 06, 2024
With undervalued S&P 500 stocks, you get the best of both worlds: the confidence from large-cap companies and a credible bargain.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
The 7 Most Undervalued Large-Cap Stocks to Buy in February 2024
February 06, 2024
All eyes are on the 'Magnificent Seven," but these seven undervalued large-cap stocks may be worth considering instead.
Via
InvestorPlace
The 3 Most Undervalued Long-Term Stocks to Buy in February 2024
February 05, 2024
These undervalued stocks for February 2024 are priced for decline, yet they are thriving businesses participating in key growth trends.
Via
InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Wall Street Favorites: 3 Undervalued Stocks With Strong Buy Ratings for January 2024
January 30, 2024
Although it may be tempting to ride the coattails of the usual suspects, investors should consider undervalued stocks January 2024.
Via
InvestorPlace
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.
Via
Benzinga
Did You Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts?
January 30, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Wall Street HATES These Three Stocks
January 29, 2024
Professional investors on Wall Street are betting against a handful of consumer stocks.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
...
40
41
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.